Multimodal imaging demonstrates enhanced tumor exposure of PEGylated FUD peptide in breast cancer-Reference-Cited by-同舟云学术

Multimodal imaging demonstrates enhanced tumor exposure of PEGylated FUD peptide in breast cancer

Published:2022-10 Issue: Volume:350 Page:284-297
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Lee Hye Jin,Gari Metti K.,Inman David R.,Rosenkrans Zachary T.,Burkel Brian M.,Olson Aeli P.,Engle Jonathan W.,Hernandez Reinier,Ponik Suzanne M.,Kwon Glen S.

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference43 articles.

1. Extracellular matrix components in breast cancer progression and metastasis;Oskarsson;Breast,2013

2. Concepts of extracellular matrix remodelling in tumour progression and metastasis;Winkler;Nat. Commun.,2020

3. The extracellular matrix in breast cancer;Insua-Rodriguez;Adv. Drug Deliv. Rev.,2016

4. Aligned collagen is a prognostic signature for survival in human breast carcinoma;Conklin;Am. J. Pathol.,2011

5. Targeted matrisome analysis identifies thrombospondin-2 and tenascin-C in aligned collagen stroma from invasive breast carcinoma;Tomko;Sci. Rep.,2018

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. [ ⁶⁴ Cu]Cu-PEG-FUD peptide for noninvasive and sensitive detection of murine pulmonary fibrosis;Science Advances;2024-04-12

2. Rationally modified SNX-class Hsp90 inhibitors disrupt extracellular fibronectin assembly without intracellular Hsp90 activity;RSC Medicinal Chemistry;2024

3. Fibronectin-targeted FUD and PEGylated FUD peptides for fibrotic diseases;Journal of Controlled Release;2023-08